2012年8月6日星期一

Biocatalysis

As pharmaceutical manufacturers increasingly use enzymatic reactions in their processes, a robust business model still eludes biocatalysis companies

Click here Cabazitaxel Cabazitaxel 183133-96-2

没有评论:

发表评论